OBJECTIVE: To adapt, implement and evaluate a model of scabies control in an Australian Aboriginal community. METHODS: After initially examining the population, we offered all residents treatment with 5% permethrin cream. Visits were made during the ensuing 25 months to rescreen and to treat new-cases of scabies and contacts. RESULTS: The prevalence of scabies was reduced from 28.8% before the program to < 10% during the entire period (from 32.3% to < 10% in children) (P < 0.01 for each visit). The initial prevalence of pyoderma in children was 69.4%, which was reduced and maintained at approximately one-half that rate during the last 16 months (P < 0.004 for the last 4 visits). Residual pyoderma in children was significantly less severe and no longer scabies-related. CONCLUSIONS: This simplified model of scabies control had a substantial effect on scabies prevalence and on pyoderma prevalence and severity which was sustained for > 2 years. It could prove useful for other communities with high rates of scabies and pyoderma.
OBJECTIVE: To adapt, implement and evaluate a model of scabies control in an Australian Aboriginal community. METHODS: After initially examining the population, we offered all residents treatment with 5% permethrin cream. Visits were made during the ensuing 25 months to rescreen and to treat new-cases of scabies and contacts. RESULTS: The prevalence of scabies was reduced from 28.8% before the program to < 10% during the entire period (from 32.3% to < 10% in children) (P < 0.01 for each visit). The initial prevalence of pyoderma in children was 69.4%, which was reduced and maintained at approximately one-half that rate during the last 16 months (P < 0.004 for the last 4 visits). Residual pyoderma in children was significantly less severe and no longer scabies-related. CONCLUSIONS: This simplified model of scabies control had a substantial effect on scabies prevalence and on pyoderma prevalence and severity which was sustained for > 2 years. It could prove useful for other communities with high rates of scabies and pyoderma.
Authors: A M Goodfellow; M Hibble; S R Talay; B Kreikemeyer; B J Currie; K S Sriprakash; G S Chhatwal Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: Milena Ml dos Santos; Salvador Amaral; Sonia P Harmen; Hayley M Joseph; Jose L Fernandes; Megan L Counahan Journal: BMC Infect Dis Date: 2010-03-10 Impact factor: 3.090
Authors: Deborah Lehmann; Mary T Tennant; Desiree T Silva; Daniel McAullay; Francis Lannigan; Harvey Coates; Fiona J Stanley Journal: BMJ Date: 2003-08-23
Authors: Kate E Mounsey; Cielo J Pasay; Larry G Arlian; Marjorie S Morgan; Deborah C Holt; Bart J Currie; Shelley F Walton; James S McCarthy Journal: Parasit Vectors Date: 2010-05-18 Impact factor: 3.876
Authors: Danielle B Clucas; Kylie S Carville; Christine Connors; Bart J Currie; Jonathan R Carapetis; Ross M Andrews Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408
Authors: Andrew C Steer; Adam W J Jenney; Joseph Kado; Michael R Batzloff; Sophie La Vincente; Lepani Waqatakirewa; E Kim Mulholland; Jonathan R Carapetis Journal: PLoS Negl Trop Dis Date: 2009-06-23
Authors: Sophie La Vincente; Therese Kearns; Christine Connors; Scott Cameron; Jonathan Carapetis; Ross Andrews Journal: PLoS Negl Trop Dis Date: 2009-05-26
Authors: Ross M Andrews; Therese Kearns; Christine Connors; Colin Parker; Kylie Carville; Bart J Currie; Jonathan R Carapetis Journal: PLoS Negl Trop Dis Date: 2009-11-24